Xiangxue Pharmaceutical (300147) — Cash Flow-to-Debt Ratio
Xiangxue Pharmaceutical (300147) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥75.64 Million could theoretically repay 0% of its total liabilities (CN¥6.27 Billion) in one year. Explore how much of Xiangxue Pharmaceutical's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xiangxue Pharmaceutical Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Xiangxue Pharmaceutical across 19 annual periods. Also explore balance sheet size of Xiangxue Pharmaceutical for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Xiangxue Pharmaceutical (2007–2025)
Year-by-year debt coverage analysis for Xiangxue Pharmaceutical. For market capitalisation and broader financial context, see 300147 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥139.63 Million | CN¥6.70 Billion | ▲ +594.7% |
| 2024 | 0.00x | CN¥18.17 Million | CN¥6.06 Billion | ▼ -93.2% |
| 2023 | 0.04x | CN¥263.44 Million | CN¥5.97 Billion | ▲ +26.9% |
| 2022 | 0.03x | CN¥227.38 Million | CN¥6.53 Billion | ▲ +3.0% |
| 2021 | 0.03x | CN¥257.56 Million | CN¥7.62 Billion | ▼ -27.4% |
| 2020 | 0.05x | CN¥257.18 Million | CN¥5.53 Billion | ▲ +143.9% |
| 2019 | 0.02x | CN¥83.02 Million | CN¥4.35 Billion | ▼ -3.5% |
| 2018 | 0.02x | CN¥91.24 Million | CN¥4.61 Billion | ▲ +0.3% |
| 2017 | 0.02x | CN¥109.53 Million | CN¥5.56 Billion | ▼ -57.3% |
| 2016 | 0.05x | CN¥198.48 Million | CN¥4.30 Billion | ▼ -68.1% |
| 2015 | 0.14x | CN¥159.89 Million | CN¥1.11 Billion | ▲ +49.9% |
| 2014 | 0.10x | CN¥165.58 Million | CN¥1.72 Billion | ▼ -48.2% |
| 2013 | 0.19x | CN¥328.37 Million | CN¥1.76 Billion | ▲ +121.0% |
| 2012 | 0.08x | CN¥118.91 Million | CN¥1.41 Billion | ▲ +43.0% |
| 2011 | 0.06x | CN¥29.55 Million | CN¥502.16 Million | ▼ -38.4% |
| 2010 | 0.10x | CN¥45.47 Million | CN¥476.01 Million | ▼ -25.4% |
| 2009 | 0.13x | CN¥46.19 Million | CN¥360.69 Million | ▼ -18.4% |
| 2008 | 0.16x | CN¥55.72 Million | CN¥354.94 Million | ▼ -58.8% |
| 2007 | 0.38x | CN¥138.02 Million | CN¥361.98 Million | — |